---
title: Exercise and Health Intervention for Patients With Obsessive Compulsive Disorder (OCD)
nct_id: NCT01242735
overall_status: COMPLETED
phase: PHASE2
sponsor: Butler Hospital
study_type: INTERVENTIONAL
primary_condition: Obsessive Compulsive Disorder
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01242735.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01242735"
ct_last_update_post_date: 2015-07-22
last_seen_at: "2026-05-12T06:00:38.185Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Exercise and Health Intervention for Patients With Obsessive Compulsive Disorder (OCD)

**Official Title:** Testing the Efficacy of an Exercise Intervention for Patients With OCD

**NCT ID:** [NCT01242735](https://clinicaltrials.gov/study/NCT01242735)

## Key Facts

- **Status:** COMPLETED
- **Phase:** PHASE2
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 56
- **Lead Sponsor:** Butler Hospital
- **Collaborators:** National Institute of Mental Health (NIMH)
- **Conditions:** Obsessive Compulsive Disorder
- **Start Date:** 2010-11
- **Completion Date:** 2015-03
- **CT.gov Last Update:** 2015-07-22

## Brief Summary

The purpose of this study is to test the effect of a moderate-intensity aerobic exercise intervention for Obsessive Compulsive Disorder (OCD) patients interested in reducing symptoms. The investigators expect that this project will contribute much needed knowledge about the role that aerobic exercise can play in managing the effects of OCD. If moderate-intensity aerobic exercise is efficacious in helping individuals with OCD manage obsessions and compulsions, this will establish that aerobic exercise may be a valuable adjunct to other OCD treatments such as medication and therapy.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 65 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

1. are between 18 and 65 years of age
2. are sedentary, i.e. have not participated in regular aerobic physical exercise for at least 90 minutes per week during the past three months
3. currently engaged in at least 12 weeks of stable dose pharmacotherapy and/or are currently engaged in cognitive-behavioral therapy for the past 13 weeks
4. meet Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) criteria for OCD as assessed by the Structured Clinical Interview for DSM Disorders, Patient Version (SCID-P)
5. have Y-BOCS score greater than 16

Exclusion Criteria:

1. DSM-IV diagnosis of substance abuse/dependence except for nicotine dependence
2. DSM-IV diagnosis of anorexia or bulimia nervosa
3. DSM-IV diagnosis of bipolar disorder
4. history of psychotic disorder or current psychotic symptoms
5. current suicidality or homicidality
6. marked organic impairment
7. physical or medical problems that would not allow for safe exercise participation
8. current pregnancy or intent to become pregnant during the next 12 weeks
```

## Arms

- **Exercise** (EXPERIMENTAL) — 12-week moderate-intensity behavioral exercise intervention (AE)
- **Health and Wellness** (ACTIVE_COMPARATOR) — 12-week health and wellness education control (HEC)

## Interventions

- **Aerobic exercise** (BEHAVIORAL) — 12-week moderate-intensity behavioral exercise intervention. Weekly sessions with an exercise physiologist who will also assign weekly exercise goals.
- **Health and Wellness** (BEHAVIORAL) — 12-week health and wellness education control. Weekly sessions about 12 different topics related to OCD, led by an OCD expert.

## Primary Outcomes

- **Yale-Brown Obsessive Compulsive Scale (Y-BOCS; OCD symptomatology)** _(time frame: 15 months)_

## Locations (1)

- Butler Hospital, Providence, Rhode Island, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.butler hospital|providence|rhode island|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01242735.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01242735*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*